Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cefozopran hydrochloride (SCE-2787 hydrochloride) 是一种半合成的非肠道头孢菌素。它是一种广谱抗菌抗生素,能抑制大多数革兰氏阴性和革兰氏阳性菌。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 272 | 5日内发货 | ||
5 mg | ¥ 465 | 5日内发货 | ||
10 mg | ¥ 600 | 5日内发货 | ||
25 mg | ¥ 750 | 5日内发货 | ||
1 mL * 10 mM (in DMSO) | ¥ 565 | 5日内发货 |
产品描述 | Cefozopran hydrochloride (SCE-2787 hydrochloride) is a fourth-generation cephalosporin. is a cell wall biosynthesis inhibitor with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. |
体外活性 | Cefozopran hydrochloride (SCE-2787 hydrochloride), a fourth-generation cephalosporin, exhibits substantial activity against a range of bacteria. Cefozopran hydrochloride is effective against gram-positive organisms, including methicillin-susceptible staphylococci, enterococci, and viridans group streptococci. Additionally, Cefozopran hydrochloride demonstrates efficacy against gram-negative organisms such as Hemophilus influenza. Notably, Cefozopran hydrochloride displays comparatively good activity against enterococci and P. aeruginosa, which are typically resistant to other cephalosporins[2]. |
体内活性 | In four-week-old ICR male mice, Cefozopran hydrochloride, administered subcutaneously at doses ranging from 5 to 80 mg/kg twice a day for 5 days, proves effective against acute respiratory tract infections caused by Kiebsiella pneumonia DT-S. In a model of chronic respiratory tract infection induced by K. pneumoniae 27, Cefozopran hydrochloride, at doses between 20 and 80 mg/kg administered subcutaneously twice a day for 7 days in five-week-old CBA/J female mice, exhibits effectiveness comparable to Ceftazidime[2]. |
别名 | SCE-2787 hydrochloride |
分子量 | 551.99 |
分子式 | C19H18ClN9O5S2 |
CAS No. | 113981-44-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 30 mg/mL (54.35 mM), Sonication is recommended.
DMSO: 30 mg/mL (54.35 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 1.8116 mL | 9.0581 mL | 18.1163 mL | 45.2907 mL |
5 mM | 0.3623 mL | 1.8116 mL | 3.6233 mL | 9.0581 mL | |
10 mM | 0.1812 mL | 0.9058 mL | 1.8116 mL | 4.5291 mL | |
20 mM | 0.0906 mL | 0.4529 mL | 0.9058 mL | 2.2645 mL | |
50 mM | 0.0362 mL | 0.1812 mL | 0.3623 mL | 0.9058 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Cefozopran hydrochloride 113981-44-5 Microbiology/Virology Antifungal Cefozopran Hydrochloride SCE2787 Hydrochloride SCE-2787 Hydrochloride SCE-2787 hydrochloride SCE 2787 Hydrochloride Inhibitor inhibitor inhibit